| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.01 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |